Results 31 to 40 of about 1,624 (132)

Invasive pulmonary aspergillosis in heart transplant recipients: Is mortality decreasing?

open access: yesRevista Portuguesa de Cardiologia, 2019
Introduction: Infection remains a major complication among heart transplant (HT) recipients, causing approximately 20% of deaths in the first year after transplantation. In this population, Aspergillus spp.
Eduardo Flores-Umanzor   +12 more
doaj   +1 more source

Levadura asociada a Infecciones Nosocomiales y su sensibilidad a los Azoles [PDF]

open access: yes, 2014
Las infecciones nosocomiales son un problema relevante de salud pública al tener gran trascendencia económica y social constituyendo un gran desafío para las instituciones de salud y para el personal médico responsable de su atención.
García Flores, Lisbet Berenice   +1 more
core  

Nasosinusal Mucormycosis - Clinical Reports and Literature Review [PDF]

open access: yes, 2011
A mucormicose e uma infecção fúngica potencialmente grave,causada por fungo saprófita. Pode tornar-se patogénico, em condições específicas, com evolução frequentemente fatal, particularmente em indivíduos imunocomprometidos.
Amaro, C   +5 more
core  

Guía de práctica clínica para la prevención, diagnóstico y tratamiento de la enfermedad tromboembólica venosa en el deporte [PDF]

open access: yes, 2015
  El término enfermedad tromboembólica venosa se refiere a varios procesos patológicos, entre los que destacan la trombosis venosa profunda, el tromboembolismo pulmonar, la hipertensión pulmonar tromboembólica crónica y el síndrome postrombótico.
Drobnic, Franchek   +4 more
core   +1 more source

A Case of Acute Lymphoblastic Leukemia Complicated with Sinonasal Mucormycosis Infection

open access: yesTurkish Journal of Internal Medicine
Acute lymphoblastic leukemia (ALL) is an aggressive hematologic malignancy of lymphoid progenitor cells. During treatment of ALL, the patients may be complicated by fatal infections such as sinonasal mucormycosis.
Asuman Şebnem Hacımustafaoğlu   +4 more
doaj   +1 more source

A Expressão Global da Doença de Chagas – Oportunidades Emergentes e Impacto em Portugal [PDF]

open access: yes, 2012
Chagas disease, caused by the protozoan Trypanosoma cruzi is endemic in the countries of Central and South America. Despite vector control programs and other measures taken in the blood banks and maternity hospitals, it is estimated that there are about ...
Cortez, J   +4 more
core  

Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics [PDF]

open access: yes, 2012
Introduction: In order to assess the significance of drug levels measured in intensive care medicine, clinical and forensic toxicology, as well as for therapeutic drug monitoring, it is essential that a comprehensive collection of data is readily ...
Andresen, Hilke   +3 more
core   +1 more source

Practical issues with the use of rivaroxaban [PDF]

open access: yes, 2013
El rivaroxabán es un inhibidor oral altamente selectivo del factor Xa. Actualmente, el uso de rivaroxabán está aprobado para la prevención del tromboembolismo venoso en adultos a los que se va a realizar un reemplazo electivo tanto de rodilla como de ...
Roldán, Vanessa   +2 more
core   +1 more source

Old and New Oral Anticoagulants. Pharmacological Perspective [PDF]

open access: yes, 2012
A terapêutica anticoagulante oral está em mudança. A varfarina e o acenocumarol constituem ainda o padrão anticoagulante oral em muitos contextos clínicos. Mas, face às limitações dos antivitamínicos K, resultantes do lento início de ação farmacológica,
Marques da Silva, P
core   +1 more source

Curso clínico de micosis producidas por Exophiala xenobiotica en paciente trasplantado renal en el Hospital Universitario de Burgos [PDF]

open access: yes, 2019
Mycosis by exophiala xenobiotica comprise a broad clinical spectrum in immunosuppressed patients, from localized to disseminated infections. They are a recognized etiology of phaeohyphomycosis, currently considered as emerging fungal infections in ...
Abáigar Luquín, Pedro   +6 more
core   +2 more sources

Home - About - Disclaimer - Privacy